NewsCorporate ActionsGenpharmasec Completes 70% Acquisition of Derren Healthcare for INR 34.15 CroresGenpharmasec Completes 70% Acquisition of Derren Healthcare for INR 34.15 Crores
Genpharmasec Limited has acquired a 70% stake in Derren Healthcare Private Limited for INR 34.15 crores. The acquisition, completed on July 25, 2025, marks Genpharmasec's entry into pharmaceutical formulations manufacturing. Derren Healthcare, a research-oriented company specializing in pharmaceutical products, has shown significant growth with its turnover increasing from INR 70.24 lacs in 2022-23 to INR 858.82 lacs in 2024-25. This strategic move is expected to enhance Genpharmasec's capabilities in the pharmaceutical sector.
*this image is generated using AI for illustrative purposes only.
Genpharmasec Limited has successfully completed the acquisition of a 70% stake in Derren Healthcare Private Limited (DHPL) for INR 34.15 crores, as announced in a regulatory filing on July 25, 2025. This strategic move marks a significant expansion for Genpharmasec into the pharmaceutical formulations manufacturing sector.
Acquisition Details
The acquisition, which was finalized on July 25, 2025, follows agreements signed in September 2023. With this transaction, Derren Healthcare has become a subsidiary of Genpharmasec Limited, in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
About Derren Healthcare
Derren Healthcare Private Limited, incorporated on October 8, 2018, is a research-oriented company specializing in the development of high-quality pharmaceutical products. The company focuses on both generic and innovative finished formulations, while also providing Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services.
Financial Performance
Derren Healthcare has demonstrated impressive growth over the past three financial years:
| Financial Year | Turnover (INR in lacs) |
|---|---|
| 2024-25 | 858.82 |
| 2023-24 | 627.69 |
| 2022-23 | 70.24 |
This rapid growth trajectory underscores the potential value of the acquisition for Genpharmasec Limited.
Strategic Implications
The acquisition allows Genpharmasec to expand its activities and make a foray into formulation manufacturing. This move is expected to enhance Genpharmasec's capabilities in the pharmaceutical sector and potentially drive future growth.
Transaction Details
The acquisition was completed through a cash consideration, with the payment made through the banking system. Genpharmasec acquired 70% of the equity shares in Derren Healthcare, which has an authorized share capital of INR 7.50 crores and a paid-up share capital of approximately INR 7.40 crores.
Mr. Sohan Chaturvedi, Whole Time Director & CFO of Genpharmasec Limited, confirmed the completion of the acquisition in the regulatory filing.
This strategic move by Genpharmasec Limited represents a significant step in its growth strategy, potentially positioning the company for expanded operations in the pharmaceutical formulations market.
Historical Stock Returns for Genpharmasec
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.57% | -0.51% | -4.43% | -3.96% | -42.94% | -71.55% |
16
